Microbiome profiling reveals gut dysbiosis in a transgenic mouse model of Huntington's disease

Neurobiology of Disease

Volumn 135, Issue , 2020, Pages

  Kong, Geraldine ^a   Cao, Kim Anh Lê ^b   Judd, Louise M ^c   Li, ShanShan ^a   Renoir, Thibault ^a   Hannan, Anthony J ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Gut microbiome; Gut brain axis; Intestinal bacteria; Microbiota; Neurodegenerative disease; Peripheral dysfunction; Polyglutamine disease; Sexual dimorphism; Tandem repeat disorder; Transgenic mice

Indexed keywords

RNA 16S; HUNTINGTIN; NERVE PROTEIN;

AMPLICON; ARTICLE; BODY WEIGHT GAIN; COMPARATIVE STUDY; CONTROLLED STUDY; DYSBIOSIS; FECES ANALYSIS; FEMALE; FIRMICUTES; FOOD INTAKE; HUNTINGTON CHOREA; INTESTINE FLORA; MALE; MICROBIAL DIVERSITY; MICROBIOME; MICROENVIRONMENT; MOLECULAR FINGERPRINTING; MOUSE; NONHUMAN; PRINCIPAL COORDINATE ANALYSIS; PRIORITY JOURNAL; SEQUENCE ANALYSIS; TRANSGENIC MOUSE; WATER CONTENT; WILD TYPE MOUSE; ANIMAL; BRAIN; DISEASE MODEL; GENETICS; METABOLISM; MOTOR ACTIVITY; PHYSIOLOGY; TRINUCLEOTIDE REPEAT;

ANIMALS; BRAIN; DISEASE MODELS, ANIMAL; DYSBIOSIS; GASTROINTESTINAL MICROBIOME; HUNTINGTIN PROTEIN; HUNTINGTON DISEASE; MALE; MICE, TRANSGENIC; MOTOR ACTIVITY; NERVE TISSUE PROTEINS; TRINUCLEOTIDE REPEAT EXPANSION;

EID: 85053727719     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2018.09.001     Document Type: Article

References (58)

1. Anderson, M.J., A new method for non-parametric multivariate analysis of variance. Austral. Ecol. 26:1 (2001), 32–46.
2. Andrich, J.E., Wobben, M., Klotz, P., Goetze, O., Saft, C., Upper gastrointestinal findings in Huntington's disease: patients suffer but do not complain. J. Neural Transm., 116(12), 2009, 1607.
3. Beal, M.F., Matson Wayne, R., Swartz Kenton, J., Gamache Paul, H., Bird Edward, D., Kynurenine pathway measurements in huntington's disease striatum: evidence for reduced formation of kynurenic acid. J. Neurochem. 55:4 (2006), 1327–1339.
4. Brooks, S.P., Janghra, N., Workman, V.L., Bayram-Weston, Z., Jones, L., Dunnett, S.B., Longitudinal analysis of the behavioural phenotype in R6/1 (C57BL/6J) Huntington's disease transgenic mice. Brain Res. Bull. 88:2–3 (2012), 94–103.
5. Callahan, B.J., McMurdie, P.J., Rosen, M.J., Han, A.W., Johnson, A.J.A., Holmes, S.P., DADA2: high-resolution sample inference from Illumina amplicon data. Nat. Methods, 13(7), 2016, 581.
6. Caporaso, J.G., Kuczynski, J., Stombaugh, J., Bittinger, K., Bushman, F.D., Costello, E.K., Gordon, J.I., QIIME allows analysis of high-throughput community sequencing data. Nat. Methods, 7(5), 2010, 335.
7. Chakraborti, C.K., New-found link between microbiota and obesity. World J. Gastrointest. Pathophysiol. 6:4 (2015), 110–119, 10.4291/wjgp.v6.i4.110.
8. Clarke, G., Grenham, S., Scully, P., Fitzgerald, P., Moloney, R., Shanahan, F., Cryan, J., The microbiome-gut-brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent manner. Mol. Psychiatry, 18(6), 2013, 666.
9. Colombo, M., Raposo, G., Théry, C., Biogenesis, Secretion, and Intercellular Interactions of Exosomes and Other Extracellular Vesicles. Annu. Rev. Cell Dev. Biol. 30:1 (2014), 255–289.
10. den Besten, G., van Eunen, K., Groen, A.K., Venema, K., Reijngoud, D.-J., Bakker, B.M., The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. J. Lipid Res. 54:9 (2013), 2325–2340.
11. Desantis, T.Z., Hugenholtz, P., Larsen, N., Rojas, M., Brodie, E.L., Keller, K., Andersen, G.L., Greengenes, a chimera-checked 16S rRNA gene database and workbench compatible with ARB. Appl. Environ. Microbiol. 72:7 (2006), 5069–5072.
12. Dixon, P., VEGAN, a package of R functions for community ecology. J. Veg. Sci. 14:6 (2009), 927–930.
13. Farhadi, F., Vosoughi, K., Shahidi, G.A., Delbari, A., Lökk, J., Fereshtehnejad, S.-M., Sexual dimorphism in Parkinson's disease: differences in clinical manifestations, quality of life and psychosocial functioning between males and females. Neuropsychiatr. Dis. Treat. 13 (2017), 329–338.
14. Foster, J.A., Neufeld, K.-A.M., Gut–brain axis: how the microbiome influences anxiety and depression. Trends Neurosci. 36:5 (2013), 305–312.
15. Gaba, A.M., Zhang, K., Marder, K., Moskowitz, C.B., Werner, P., Boozer, C.N., Energy balance in early-stage Huntington disease. Am. J. Clin. Nutr. 81:6 (2005), 1335–1341.
16. Giloteaux, L., Goodrich, J.K., Walters, W.A., Levine, S.M., Ley, R.E., Hanson, M.R., Reduced diversity and altered composition of the gut microbiome in individuals with myalgic encephalomyelitis/chronic fatigue syndrome. Microbiome, 4(1), 2016, 30.
17. Golubeva, A.V., Joyce, S.A., Moloney, G., Burokas, A., Sherwin, E., Arboleya, S., Cryan, J.F., Microbiota-related changes in Bile Acid & Tryptophan Metabolism are Associated with Gastrointestinal Dysfunction in a Mouse Model of Autism. EBioMedicine 24 (2017), 166–178.
18. Greenblum, S., Turnbaugh, P.J., Borenstein, E., Metagenomic systems biology of the human gut microbiome reveals topological shifts associated with obesity and inflammatory bowel disease. Proc. Natl. Acad. Sci. 109:2 (2012), 594–599.
19. Haro, C., Rangel-Zúñiga, O.A., Alcalá-Díaz, J.F., Gómez-Delgado, F., Pérez-Martínez, P., Delgado-Lista, J., Tena-Sempere, M., Intestinal microbiota is influenced by gender and body mass index. PLoS One, 11(5), 2016, e0154090.
20. Hoban, A.E., Stilling, R.M., Moloney, G., Shanahan, F., Dinan, T.G., Clarke, G., Cryan, J.F., The microbiome regulates amygdala-dependent fear recall. [Original Article]. Mol. Psychiatry, 2017, 10.1038/mp.2017.100.
21. Hoss, A.G., Labadorf, A., Latourelle, J.C., Kartha, V.K., Hadzi, T.C., Gusella, J.F., Weng, Z., miR-10b-5p expression in Huntington's disease brain relates to age of onset and the extent of striatal involvement. BMC Med. Genet., 8(1), 2015, 10.
22. Hsiao, E.Y., McBride, S.W., Hsien, S., Sharon, G., Hyde, E.R., McCue, T., Petrosino, J.F., Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders. Cell 155:7 (2013), 1451–1463.
23. Jiao, S.-S., Bu, X.-L., Liu, Y.-H., Zhu, C., Wang, Q.-H., Shen, L.-L., Wang, Y.-J., Sex Dimorphism Profile of Alzheimer's Disease-Type Pathologies in an APP/PS1 Mouse Model. Neurotox. Res. 29:2 (2016), 256–266.
24. Kessler, R.C., McGonagle, K.A., Zhao, S., Nelson, C.B., Hughes, M., Eshleman, S., Kendler, K.S., Lifetime and 12-month prevalence of dsm-iii-r psychiatric disorders in the United States: results from the national comorbidity survey. Arch. Gen. Psychiatry 51:1 (1994), 8–19.
25. Kim, J., Moody, J.P., Edgerly, C.K., Bordiuk, O.L., Cormier, K., Smith, K., Ferrante, R.J., Mitochondrial loss, dysfunction and altered dynamics in Huntington's disease. Hum. Mol. Genet. 19:20 (2010), 3919–3935.
26. Koroshetz, W.J., Jenkins, B.G., Rosen, B.R., Beal, M.F., Energy metabolism defects in Huntington's disease and effects of coenzyme Q10. Ann. Neurol. 41:2 (1997), 160–165.
27. Langille, M.G., Zaneveld, J., Caporaso, J.G., McDonald, D., Knights, D., Reyes, J.A., Knight, R., Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences. Nat. Biotechnol., 31(9), 2013, 814.
28. Lê Cao, K.-A., Costello, M.-E., Lakis, V.A., Bartolo, F., Chua, X.-Y., Brazeilles, R., Rondeau, P., MixMC: a Multivariate Statistical Framework to Gain Insight into Microbial Communities. PLoS One, 11(8), 2016, e0160169.
29. Lee, S.-T., Chu, K., Im, W.-S., Yoon, H.-J., Im, J.-Y., Park, J.-E., Roh, J.-K., Altered microRNA regulation in Huntington's disease models. Exp. Neurol. 227:1 (2011), 172–179.
30. Ley, R.E., Bäckhed, F., Turnbaugh, P., Lozupone, C.A., Knight, R.D., Gordon, J.I., Obesity alters gut microbial ecology. Proc. Natl. Acad. Sci. U. S. A., 102(31), 2005, 11070.
31. Li, R., Singh, M., Sex differences in Cognitive Impairment and Alzheimer's Disease. Front. Neuroendocrinol. 35:3 (2014), 385–403.
32. Liu, S., da Cunha, A.P., Rezende, R.M., Cialic, R., Wei, Z., Bry, L., Weiner, H.L., The host shapes the gut microbiota via fecal microRNA. Cell Host Microbe 19:1 (2016), 32–43.
33. Mo, C., Pang, T.Y., Ransome, M.I., Hill, R.A., Renoir, T., Hannan, A.J., High stress hormone levels accelerate the onset of memory deficits in male Huntington's disease mice. Neurobiol. Dis. 69 (2014), 248–262.
34. Moffitt, H., McPhail, G.D., Woodman, B., Hobbs, C., Bates, G.P., Formation of Polyglutamine Inclusions in a Wide Range of Non-CNS Tissues in the HdhQ150 Knock-in Mouse Model of Huntington's Disease. PLoS One 4:11 (2009), e8025–e8035.
35. Ogbonnaya, E.S., Clarke, G., Shanahan, F., Dinan, T.G., Cryan, J.F., O'Leary, O.F., Adult hippocampal neurogenesis is regulated by the microbiome. Biol. Psychiatry 78:4 (2015), e7–e9.
36. Oliveira, J.M., Jekabsons, M.B., Chen, S., Lin, A., Rego, A.C., Goncalves, J., Nicholls, D.G., Mitochondrial dysfunction in Huntington's disease: the bioenergetics of isolated and in situ mitochondria from transgenic mice. J. Neurochem. 101:1 (2007), 241–249.
37. Org, E., Mehrabian, M., Parks, B.W., Shipkova, P., Liu, X., Drake, T.A., Lusis, A.J., Sex differences and hormonal effects on gut microbiota composition in mice. Gut Microbes 7:4 (2016), 313–322.
38. Packer, A.N., Xing, Y., Harper, S.Q., Jones, L., Davidson, B.L., The bi-functional microRNA miR-9/miR-9* regulates REST and CoREST and is down-regulated in Huntington's Disease. J. Neurosci. 28:53 (2008), 14341–14346.
39. Péronnet, F., Mignault, D., du Souich, P., Vergne, S., Le Bellego, L., Jimenez, L., Rabasa-Lhoret, R., Pharmacokinetic analysis of absorption, distribution and disappearance of ingested water labeled with D(2)O in humans. Eur. J. Appl. Physiol. 112:6 (2012), 2213–2222.
40. Pratley, R.E., Salbe, A.D., Ravussin, E., Caviness, J.N., Higher sedentary energy expenditure in patients with Huntington's disease. Ann. Neurol. 47:1 (2000), 64–70.
41. Price, M.N., Dehal, P.S., Arkin, A.P., FastTree 2–approximately maximum-likelihood trees for large alignments. PLoS One, 5(3), 2010, e9490.
42. Qin, J., Li, Y., Cai, Z., Li, S., Zhu, J., Zhang, F., Shen, D., A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature, 490(7418), 2012, 55.
43. Roager, H.M., Hansen, L.B.S., Bahl, M.I., Frandsen, H.L., Carvalho, V., Gøbel, R.J., Licht, T.R., Colonic transit time is related to bacterial metabolism and mucosal turnover in the gut. [Article]. Nat. Microbiol., 1, 2016, 16093.
44. Rohart, F., Gautier, B., Singh, A., Lê Cao, K.-A., mixOmics: an R package for ‘omics feature selection and multiple data integration. PLoS Comput. Biol., 13(11), 2017, e1005752.
45. Sampson, T.R., Debelius, J.W., Thron, T., Janssen, S., Shastri, G.G., Ilhan, Z.E., Gradinaru, V., Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson's disease. Cell 167:6 (2016), 1469–1480 e1412.
46. Sathasivam, K., Hobbs, C., Turmaine, M., Mangiarini, L., Mahal, A., Bertaux, F., Bates, G.P., Formation of polyglutamine inclusions in non-CNS tissue. Hum. Mol. Genet. 8:5 (1999), 813–822.
47. Scheperjans, F., Aho, V., Pereira, P.A., Koskinen, K., Paulin, L., Pekkonen, E., Pohja, M., Gut microbiota are related to Parkinson's disease and clinical phenotype. Mov. Disord. 30:3 (2015), 350–358.
48. Sharp, A.H., Loev, S.J., Schilling, G., Li, S.-H., Li, X.-J., Bao, J., Ross, C.A., Widespread Expression of Huntington's Disease Gene (IT15) Protein Product. Neuron 14:5 (1995), 1065–1074.
49. Stilling, R.M., Ryan, F.J., Hoban, A.E., Shanahan, F., Clarke, G., Claesson, M.J., Cryan, J.F., Microbes & neurodevelopment – Absence of microbiota during early life increases activity-related transcriptional pathways in the amygdala. Brain Behav. Immun. 50 (2015), 209–220.
50. The Huntington's Disease Collaborative Research Group. A Novel Gene Containing a Trinucleotide Repeat that Is Expanded and Unstable on Huntington's Disease Chromosomes Cell, 72, 971–983. 1993.
51. Turnbaugh, P.J., Ley, R.E., Mahowald, M.A., Magrini, V., Mardis, E.R., Gordon, J.I., An obesity-associated gut microbiome with increased capacity for energy harvest. Nature, 444(7122), 2006, 1027.
52. van der Burg, J.M.M., Winqvist, A., Aziz, N.A., Maat-Schieman, M.L.C., Roos, R.A.C., Bates, G.P., Wierup, N., Gastrointestinal dysfunction contributes to weight loss in Huntington's disease mice. Neurobiol. Dis., 44(1), 2011, 1.
53. Van Niel, G., Raposo, G., Candalh, C., Boussac, M., Hershberg, R., Cerf–Bensussan, N., & Heyman, M. (2001). Intestinal epithelial cells secrete exosome–like vesicles. Gastroenterology, 121(2), 337–349.
54. Vandeputte, D., Falony, G., Vieira-Silva, S., Tito, R. Y., Joossens, M., & Raes, J. (2015). Stool consistency is strongly associated with gut microbiota richness and composition, enterotypes and bacterial growth rates. [ https://doi.org/10.1136/gutjnl-2015-309618]. Gut.
55. Verwaest, K.A., Vu, T.N., Laukens, K., Clemens, L.E., Nguyen, H.P., Van Gasse, B., Dommisse, R., 1H NMR based metabolomics of CSF and blood serum: a metabolic profile for a transgenic rat model of Huntington disease. Biochim. Biophys. Acta (BBA) - Mol. Basis Dis. 1812:11 (2011), 1371–1379.
56. Vogt, N.M., Kerby, R.L., Dill-McFarland, K.A., Harding, S.J., Merluzzi, A.P., Johnson, S.C., Rey, F.E., Gut microbiome alterations in Alzheimer's disease. Sci. Rep., 7(1), 2017, 13537.
57. Wood, N.I., Goodman, A.O., van der Burg, J.M., Gazeau, V., Brundin, P., Björkqvist, M., Morton, A.J., Increased thirst and drinking in Huntington's disease and the R6/2 mouse. Brain Res. Bull. 76:1–2 (2008), 70–79.
58. Zheng, P., Zeng, B., Zhou, C., Liu, M., Fang, Z., Xu, X., Xie, P., Gut microbiome remodeling induces depressive-like behaviors through a pathway mediated by the host's metabolism. [Original Article]. Mol. Psychiatry, 21, 2016, 786.